ING Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-210,000	Closed	-$18.3M	–	548
2024 Q1	$18.3M	Hold	210,000	–	–	0.13%	142
2023 Q4	$20.2M	Buy	+210,000	New	+$18.6M	0.16%	128
2019 Q2	–	Sell	-5,814	Closed	-$516K	–	760
2019 Q1	$516K	Sell	5,814 -3,077	-35%	-$285K	0.01%	444
2018 Q4	$757K	Sell	8,891 -3,649	-29%	-$347K	0.02%	381
2018 Q3	$1.22M	Buy	12,540 +8,805	+236%	+$879K	0.02%	332
2018 Q2	$352K	Buy	3,735 +100	+3%	+$8.76K	0.01%	575
2018 Q1	$295K	Sell	3,635 -1,087	-23%	-$93.3K	0.01%	621
2017 Q4	$421K	Sell	4,722 -728	-13%	-$63.3K	0.01%	546
2017 Q3	$507K	Buy	+5,450	New	+$482K	0.01%	469
2016 Q3	–	Sell	-737,335	Closed	-$57.4M	–	573
2016 Q2	$57.4M	Buy	+737,335	New	+$62.7M	0.77%	28
2016 Q1	–	Sell	-25,700	Closed	-$2.69M	–	552
2015 Q4	$2.69M	Buy	25,700 +10,240	+66%	+$1.07M	0.02%	385
2015 Q3	$1.63M	Buy	15,460 +12,983	+524%	+$1.73M	0.01%	392
2015 Q2	$339K	Sell	2,477 -254,061	-99%	-$31.5M	﹤0.01%	585
2015 Q1	$32M	Buy	+256,538	New	+$27.2M	0.16%	144
2013 Q4	–	Sell	-186,953	Closed	-$13.5M	–	695
2013 Q3	$13.5M	Buy	+186,953	New	+$12.4M	0.07%	256